219 related articles for article (PubMed ID: 9401168)
1. Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization, and future intentions.
Mercer SL; Goel V; Levy IG; Ashbury FD; Iverson DC; Iscoe NA
Can J Public Health; 1997; 88(5):327-32. PubMed ID: 9401168
[TBL] [Abstract][Full Text] [Related]
2. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
[TBL] [Abstract][Full Text] [Related]
3. Prostate Cancer Knowledge, Prevention, and Screening Behaviors in Jamaican Men.
Morrison BF; Aiken WD; Mayhew R; Gordon Y; Odedina FT
J Cancer Educ; 2017 Jun; 32(2):352-356. PubMed ID: 26842816
[TBL] [Abstract][Full Text] [Related]
4. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen testing: men's responses to 2012 recommendation against screening.
Squiers LB; Bann CM; Dolina SE; Tzeng J; McCormack L; Kamerow D
Am J Prev Med; 2013 Aug; 45(2):182-9. PubMed ID: 23867025
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer screening: Knowledge, attitudes and practices in a sample of men in Italy. A survey.
Morlando M; Pelullo CP; Di Giuseppe G
PLoS One; 2017; 12(10):e0186332. PubMed ID: 29023514
[TBL] [Abstract][Full Text] [Related]
7. Factors Influencing Prostate Cancer Screening Intentions in Lebanese Men.
Hejase R; Saleh AM; Abdel-Aziz HR; Vellaiyan A; AlOmari AK; AlOmari AA
Asian Pac J Cancer Prev; 2024 Mar; 25(3):963-970. PubMed ID: 38546078
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
Agalliu I; Weiss NS; Lin DW; Stanford JL
Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen and digital rectal examination in screening for prostate cancer: a community-based study.
Bretton PR
South Med J; 1994 Jul; 87(7):720-3. PubMed ID: 7517580
[TBL] [Abstract][Full Text] [Related]
11. Lifetime and recent prostate specific antigen (PSA) screening of men for prostate cancer in Canada.
Beaulac JA; Fry RN; Onysko J
Can J Public Health; 2006; 97(3):171-6. PubMed ID: 16827400
[TBL] [Abstract][Full Text] [Related]
12. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
[TBL] [Abstract][Full Text] [Related]
13. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial.
Gattellari M; Ward JE
J Med Screen; 2003; 10(1):27-39. PubMed ID: 12790313
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
[TBL] [Abstract][Full Text] [Related]
15. GP and patient predictors of PSA screening in Australian general practice.
Gattellari M; Young JM; Ward JE
Fam Pract; 2003 Jun; 20(3):294-303. PubMed ID: 12738699
[TBL] [Abstract][Full Text] [Related]
16. Patterns in prostate-specific antigen test use and digital rectal examinations in the Behavioral Risk Factor Surveillance System, 2002-2006.
Ross LE; Taylor YJ; Richardson LC; Howard DL
J Natl Med Assoc; 2009 Apr; 101(4):316-24. PubMed ID: 19397221
[TBL] [Abstract][Full Text] [Related]
17. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
[TBL] [Abstract][Full Text] [Related]
18. Knowledge, attitudes, and screening practices among older men regarding prostate cancer.
Steele CB; Miller DS; Maylahn C; Uhler RJ; Baker CT
Am J Public Health; 2000 Oct; 90(10):1595-600. PubMed ID: 11029994
[TBL] [Abstract][Full Text] [Related]
19. Public awareness of prostate cancer and the prostate-specific antigen test.
Mainous AG; Hagen MD
Cancer Pract; 1994; 2(3):217-21. PubMed ID: 7519944
[TBL] [Abstract][Full Text] [Related]
20. Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.
Howard K; Salkeld GP; Patel MI; Mann GJ; Pignone MP
Health Expect; 2015 Dec; 18(6):3123-35. PubMed ID: 25382490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
